Toronto Stock Exchange Symbol: CYT
MONTREAL, July 30 /CNW/ - CryoCath Technologies Inc. (TSX: CYT), the
global leader in cryotherapy products to treat cardiac arrhythmias, today
announced that Jan Keltjens, President and CEO of CryoCath, will present a
corporate update at the BMO Focus on Healthcare Conference. The Company's
presentation will take place Wednesday, August 6th at 8:30 a.m. (ET) in Room 2
at the Millennium Broadway Hotel in New York City.
Interested parties may access a live webcast of Mr. Keltjens'
presentation by visiting the company's website at www.cryocath.com.
CryoCath - www.cryocath.com - is a medical technology company that leads
the world in cryotherapy products to treat cardiac arrhythmias. With a
priority focus on providing physicians with a complete solution of catheter
products to treat cardiac arrhythmias, CryoCath has multiple products approved
in the U.S., across Europe and several ROW countries. The Company is
developing additional products to expand its pipeline of products to treat
This press release includes "forward-looking statements" that are subject
to risks and uncertainties, including with respect to the timing of regulatory
trials and their outcome. For information identifying legislative or
regulatory, economic, climatic, currency, technological, competitive and other
important factors that could cause actual results to differ materially from
those anticipated in the forward looking statements, see CryoCath's annual
report available at www.sedar.com under the heading Risks and Uncertainties in
the Management's Discussion and Analysis section.
For further information:
For further information: visit our website at www.cryocath.com, or
contact: Ross Marshall, Investor Relations, Phone: (416) 815-0700 ext. 238,
Fax : (416) 815-0080, E-mail: firstname.lastname@example.org